JoVE Logo

Sign In

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.

Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing arteries, constricting the vital blood flow. When a plaque ruptures, it forms a clot that further blocks the coronary artery. This cataclysmic event can result in angina, myocardial infarction, heart failure, or sudden cardiac death.

Various factors contribute to the ominous realm of ischemic heart disease. Age, gender, family history, smoking, elevated blood pressure and cholesterol, obesity, diabetes, and stress all weave a complex web of susceptibility.

Fortitude against this silent menace lies in proactive measures. Lifestyle changes, an armor of healthy choices, fortify hearts against impending threats. Yet, modern medicine stands as a stalwart ally. Medications such as aspirin, ACE inhibitors, organic nitrates, and beta-blockers offer a shield against the insidious advances of ischemic heart disease.

Medical intervention takes a more aggressive stance when the disease tightens its grip. Invasive procedures, like angioplasty or bypass surgery, become the beacon of hope. They pave the way for restoring adequate blood flow, rescuing the heart from the clutches of this silent yet potent adversary.

Tags
Ischemic Heart DiseaseBlood SupplyOxygen DeficiencyAtherosclerosisFatty DepositsArterial WallsCoronary ArteryAnginaMyocardial InfarctionHeart FailureRisk FactorsLifestyle ChangesMedicationsACE InhibitorsAngioplastyBypass Surgery

From Chapter 11:

article

Now Playing

11.5 : Ischemic Heart Disease: Overview

Cardiovascular Drugs: Anticoagulants and Antianginal Agents

712 Views

article

11.1 : Anticoagulant Drugs: Low-Molecular-Weight Heparins

Cardiovascular Drugs: Anticoagulants and Antianginal Agents

311 Views

article

11.2 : Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Cardiovascular Drugs: Anticoagulants and Antianginal Agents

584 Views

article

11.3 : Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Cardiovascular Drugs: Anticoagulants and Antianginal Agents

196 Views

article

11.4 : Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Cardiovascular Drugs: Anticoagulants and Antianginal Agents

354 Views

article

11.6 : Antianginal Drugs: Nitrates and β-Blockers

Cardiovascular Drugs: Anticoagulants and Antianginal Agents

293 Views

article

11.7 : Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Cardiovascular Drugs: Anticoagulants and Antianginal Agents

290 Views

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2025 MyJoVE Corporation. All rights reserved